Lamin B receptor plays a key role in cellular senescence induced by inhibition of the proteasome.


Journal

FEBS open bio
ISSN: 2211-5463
Titre abrégé: FEBS Open Bio
Pays: England
ID NLM: 101580716

Informations de publication

Date de publication:
02 2020
Historique:
revised: 07 11 2019
received: 13 07 2019
accepted: 09 12 2019
pubmed: 12 12 2019
medline: 4 1 2022
entrez: 12 12 2019
Statut: ppublish

Résumé

Cellular senescence is a terminal growth arrest phenomenon in mammalian cells. Coordinated regulation of protein synthesis and degradation is required to maintain protein homeostasis in cells; however, senescent cells exhibit decreased activity of the proteasome, a major cellular proteolytic machinery, with an accumulation of proteins. Indeed, we showed that MG132, a proteasome inhibitor, induced cellular senescence through an accumulation of proteins in human cells. We then investigated the mechanisms of cellular senescence induced by protein accumulation by treating cells with MG132. We found that lamin B receptor (LBR), a nuclear membrane protein that regulates heterochromatin organization, was mislocalized and down-regulated in cells on treatment with MG132. Importantly, enforced expression of LBR suppressed cellular senescence induced by MG132. We also showed that LBR was involved in the regulation of chromatin organization in senescent cells, and that endoplasmic reticulum stress and autophagy were likely to be involved in the mislocalization and down-regulation of LBR. These findings indicate that decreased LBR function was responsible for the induction of cellular senescence by MG132, and thus suggest that protein accumulation caused by inhibition of the proteasome induced cellular senescence probably through chromatin dysregulation in human cells.

Identifiants

pubmed: 31825172
doi: 10.1002/2211-5463.12775
pmc: PMC6996348
doi:

Substances chimiques

Chromatin 0
Lamin Type B 0
Leupeptins 0
Membrane Proteins 0
Receptors, Cytoplasmic and Nuclear 0
Proteasome Endopeptidase Complex EC 3.4.25.1
benzyloxycarbonylleucyl-leucyl-leucine aldehyde RF1P63GW3K

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-250

Informations de copyright

© 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

Références

Oncogene. 2010 Jan 21;29(3):451-62
pubmed: 19881538
Exp Cell Res. 2016 Aug 15;346(2):216-23
pubmed: 27443255
Mol Cell Biol. 2004 Nov;24(22):9695-704
pubmed: 15509775
J Biol Chem. 1996 Jun 21;271(25):14653-6
pubmed: 8663349
J Cell Physiol. 2006 Jun;207(3):845-53
pubmed: 16523493
Autophagy. 2008 Oct;4(7):849-50
pubmed: 18758232
Proc Natl Acad Sci U S A. 1988 Nov;85(22):8531-4
pubmed: 2847165
Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40
pubmed: 17667954
Am J Pathol. 2007 Aug;171(2):513-24
pubmed: 17620365
Biosci Biotechnol Biochem. 2004 Nov;68(11):2395-7
pubmed: 15564682
Biosci Biotechnol Biochem. 2008 Apr;72(4):1122-5
pubmed: 18391457
Mech Ageing Dev. 2019 Mar;178:25-32
pubmed: 30615890
J Biol Chem. 2003 Jul 25;278(30):28026-37
pubmed: 12736271
Trends Genet. 2016 Nov;32(11):751-761
pubmed: 27692431
Sci Rep. 2016 Jan 05;6:18722
pubmed: 26729469
EMBO Rep. 2001 Oct;2(10):920-5
pubmed: 11571267
Trends Cell Biol. 2012 Aug;22(8):407-17
pubmed: 22748206
Cell. 2013 Jan 31;152(3):584-98
pubmed: 23374351
J Cell Biol. 1997 Sep 22;138(6):1193-206
pubmed: 9298976
J Biol Chem. 2012 Dec 14;287(51):42654-63
pubmed: 23100253
Exp Cell Res. 2009 Jul 1;315(11):1895-903
pubmed: 19331822
Exp Cell Res. 2016 Jul 15;345(2):239-46
pubmed: 27339653
Biochem Biophys Res Commun. 2005 Sep 23;335(2):558-65
pubmed: 16083852
Biogerontology. 2004;5(1):55-61
pubmed: 15138382
J Biochem. 1999 Dec;126(6):1052-9
pubmed: 10578056
Biochem Biophys Res Commun. 2016 May 13;473(4):1078-1083
pubmed: 27059139
Biochem Pharmacol. 1965 Dec;14(12):1821-9
pubmed: 5880537
Biochem J. 2017 Jan 15;474(2):281-300
pubmed: 27760841
Pharmacol Res Perspect. 2016 Feb 04;4(1):e00211
pubmed: 26977301
Free Radic Biol Med. 2014 Jun;71:303-320
pubmed: 24681338
Exp Cell Res. 1961 Dec;25:585-621
pubmed: 13905658
Science. 1964 Dec 11;146(3650):1474-6
pubmed: 14208575
J Biol Chem. 1996 Nov 1;271(44):27280-4
pubmed: 8910302
Cancer Res. 2005 Dec 15;65(24):11510-9
pubmed: 16357160
Blood Cells. 1983;9(1):57-68
pubmed: 6683114
Exp Gerontol. 2004 Feb;39(2):173-9
pubmed: 15036409
Anal Biochem. 1987 Apr;162(1):156-9
pubmed: 2440339

Auteurs

Atsuki En (A)

Graduate School of Nanobioscience, Yokohama City University, Japan.

Yuki Takauji (Y)

Graduate School of Nanobioscience, Yokohama City University, Japan.
Ichiban Life Corporation, Yokohama, Japan.

Kensuke Miki (K)

Graduate School of Nanobioscience, Yokohama City University, Japan.
Ichiban Life Corporation, Yokohama, Japan.

Dai Ayusawa (D)

Graduate School of Nanobioscience, Yokohama City University, Japan.
Ichiban Life Corporation, Yokohama, Japan.

Michihiko Fujii (M)

Graduate School of Nanobioscience, Yokohama City University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH